ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이러스 벡터 서비스 시장 규모는 최근 수년간 비약적으로 확대되고 있습니다. 2024년 20억 4,000만 달러로 평가되었고, 2025년에는 25억 3,000만 달러에 달할 것으로 추정되며, CAGR 24.4%로 성장이 전망되고 있습니다. 지금까지의 성장은 바이오테크놀러지 연구에 대한 정부 자금 증가, 제약 기업에 의한 바이러스 벡터 제조에 대한 투자 확대, 유전자 도입 연구에 있어서 학술 연계 강화, 바이러스 벡터를 이용한 백신 개발의 대처 확대, 진보적인 치료법에 대한 인식 증가와 관련이 있습니다.
바이러스 벡터 서비스 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 59억 9,000만 달러에 달할 것으로 예측되며, CAGR 24.0%로 성장할 전망입니다. 예측 기간에 있어서의 성장요인으로는 CDMO에 대한 바이러스 벡터 생산의 아웃소싱 증가, 대규모 제조 능력 확충에 대한 주목의 고조, 효율적인 벡터 공급망에 대한 수요 증가, 바이오 의약품 제조 인프라의 계속적 확충, 벡터 생산에 있어서 자동화의 도입 증가 등을 들 수 있습니다. 예측 기간 동안 예상되는 주요 동향은 모듈형 바이오프로세스 시스템의 혁신, 디지털 트윈 기술의 발전, 연속 제조 플랫폼 개발, 공정 분석 기술(PAT)의 발전, 로봇 공학 및 AI 구동 최적화의 바이러스 벡터 생산에의 통합을 포함합니다.
감염의 확산은 향후 수년간 바이러스 벡터 서비스 시장의 성장을 이끌 것으로 예측됩니다. 감염은 박테리아, 바이러스, 곰팡이, 기생충과 같은 병원성 미생물에 의해 유발되며 사람에서 사람으로 직접 또는 간접적으로 전염됩니다. 감염증의 발생률은 상승 경향에 있으며, 그 원인은 병원체의 국경을 넘은 급속한 확산을 조장하는 국제적인 이동 증가를 들 수 있습니다. 바이러스 벡터 서비스는 백신과 유전자 치료제의 개발을 위한 신뢰할 수 있는 플랫폼을 제공함으로써 감염증 대책에서 매우 중요한 역할을 하고 있습니다. 이러한 서비스는 표적 세포에 유전 물질의 효율적인 전달을 가능하게 하고 효과적인 치료의 개발을 가속화하며 공중 보건 대응을 개선합니다. 예를 들어, 2024년 2월에 영국 정부 기관인 영국 보건 안보청이 발표한 바에 의하면, 잉글랜드에서 결핵(주로 폐에 영향을 미치는 전염성 세균 감염증)의 증례 수는 2023년에 4,850건에 달했으며, 2022년의 4,380건으로부터 10.7% 증가했습니다. 이와 같이 감염증의 만연 확대가 바이러스 벡터 서비스 시장의 확대를 견인하고 있습니다.
바이러스 벡터 서비스 시장의 주요 기업은 4세대 벡터 시스템 등 렌티바이러스 벡터의 설계 및 제조에 있어서 혁신에 주력하고 있습니다. 이러한 첨단 시스템은 페이로드 용량, 효능 및 안전성을 향상시키는 동시에 복잡한 유전자 치료의 개발을 효율화하도록 설계되었습니다. 4세대 벡터 시스템은 안전성 프로파일 개선, 최적화된 유전자 패키징 능력 및 모듈식 컴포넌트로 설계되어 세포 및 유전자 치료를 위한 확장 가능한 플러그 앤 플레이 제조를 가능하게 합니다. 예를 들어, 2023년 5월에는 영국에 본사를 둔 바이러스 벡터 수탁 개발 제조 기관(CDMO)인 Oxford Biomedica plc가 TetraVecta 시스템을 발표했습니다. 이 시스템은 벡터의 품질, 효력, 포장 효율을 향상시키는 동시에 고급 안전 기능도 통합하고 있습니다. 고 역가, 안정적인 생산 세포주 생성을 촉진하고 확장 가능한 생체 내 유전자 치료 개발을 지원합니다. TetraVecta는 제조 공정의 합리화에 기여하고, 생산 스케줄을 단축함과 동시에, 유전자 치료 프로그램 전체의 효율 향상을 실현합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 바이러스 벡터 서비스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 바이러스 벡터 서비스 시장 : 성장률 분석
세계의 바이러스 벡터 서비스 시장 실적 : 규모 및 성장(2019-2024년)
세계의 바이러스 벡터 서비스 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 바이러스 벡터 서비스 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 바이러스 벡터 서비스 시장 : 서비스 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
프로세스 개발
제조
품질관리
기타 서비스 유형
세계의 바이러스 벡터 서비스 시장 : 벡터 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
아데노바이러스 벡터
렌티바이러스 벡터
아데노 관련 바이러스 벡터
레트로바이러스 벡터
기타 벡터 유형
세계의 바이러스 벡터 서비스 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
유전자 치료
백신학
종양
기타 용도
세계의 바이러스 벡터 서비스 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제약 및 생명 공학 기업
연구기관
기타 최종 사용자
세계의 바이러스 벡터 서비스 시장 : 프로세스 개발 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
벡터 디자인
어세이 개발
세포주 개발
프로세스 최적화
세계의 바이러스 벡터 서비스 시장 : 제조 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
업스트림 공정 생산
다운스트림 공정에서의 정제
제제 개발
스케일업 생산
세계의 바이러스 벡터 서비스 시장 : 품질 관리 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
분석 시험
안전성 시험
효력 시험
안정성 시험
제7장 지역별 및 국가별 분석
세계의 바이러스 벡터 서비스 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 바이러스 벡터 서비스 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
바이러스 벡터 서비스 시장 : 경쟁 구도
바이러스 벡터 서비스 시장 : 기업 프로파일
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Lonza Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
FUJIFILM Diosynth Biotechnologies : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sartorius AG
CJ CheilJedang Corp.
Charles River Laboratories Inc.
Takara Bio Inc.
Oxford Biomedica plc
ProBioGen AG
NorthX Biologics Ltd.
PackGene Biotech Ltd.
Ascend Advanced Therapies Ltd.
VectorBuilder Inc.
ViroCell Biologics Ltd.
Genezen Ltd.
Scorpius BioManufacturing Ltd.
VGXI Inc.
Creative Biogene Ltd.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
바이러스 벡터 서비스 시장(2009년) : 새로운 기회를 제공하는 국가
바이러스 벡터 서비스 시장(2009년) : 새로운 기회를 제공하는 부문
바이러스 벡터 서비스 시장(2009년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Viral vector service refers to the activities involved in designing, producing, and validating viral vectors used to deliver genes in both research and therapeutic settings. These services support the safe and efficient transfer of genetic material into target cells for developing advanced biologics and gene therapies. They ensure high-quality vector production by following standardized procedures and adhering to regulatory requirements.
The primary service types within viral vector services include process development, manufacturing, quality control, and others. Process development involves the systematic design, optimization, and scaling of a production or manufacturing process to ensure efficiency, consistency, and compliance with quality standards. These services are applied to a range of vector types, such as adenoviral vectors, lentiviral vectors, adeno-associated viral (AAV) vectors, retroviral vectors, and more. They are utilized in applications such as gene therapy, vaccinology, oncology, and others, and serve end users including pharmaceutical and biotechnology companies, research institutions, and additional stakeholders.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The viral vector service market research report is one of a series of new reports from The Business Research Company that provides viral vector service market statistics, including the viral vector service industry global market size, regional shares, competitors with the viral vector service market share, detailed viral vector service market segments, market trends, and opportunities, and any further data you may need to thrive in the viral vector service industry. This viral vector service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The viral vector service market size has grown exponentially in recent years. It will grow from $2.04 billion in 2024 to $2.53 billion in 2025 at a compound annual growth rate (CAGR) of 24.4%. Growth during the historic period can be linked to increased government funding for biotechnology research, rising investment by pharmaceutical companies in viral vector manufacturing, greater academic collaboration in gene delivery research, expansion of vaccine development efforts using viral vectors, and growing awareness of advanced therapeutic modalities.
The viral vector service market size is expected to see exponential growth in the next few years. It will grow to $5.99 billion in 2029 at a compound annual growth rate (CAGR) of 24.0%. Growth in the forecast period can be attributed to the rising outsourcing of viral vector production to CDMOs, heightened focus on expanding large-scale manufacturing capacity, growing demand for efficient vector supply chains, continued expansion of biopharmaceutical manufacturing infrastructure, and increasing adoption of automation in vector production. Key trends anticipated in the forecast period include innovations in modular bioprocessing systems, advancements in digital twin technologies, the development of continuous manufacturing platforms, progress in process analytical technologies (PAT), and the integration of robotics and AI-driven optimization into viral vector production.
The increasing prevalence of infectious diseases is expected to drive the growth of the viral vector services market in the coming years. Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, and can be transmitted directly or indirectly from one person to another. The incidence of infectious diseases is rising, partly due to increased global travel, which facilitates the rapid spread of pathogens across borders. Viral vector services play a critical role in managing infectious diseases by providing reliable platforms for the development of vaccines and gene-based therapeutics. These services enable the efficient delivery of genetic material to target cells, speeding up the development of effective treatments and improving public health responses. For example, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis (a contagious bacterial infection primarily affecting the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. As such, the growing prevalence of infectious diseases is driving the expansion of the viral vector services market.
Key companies in the viral vector services market are focusing on innovations in lentiviral vector design and manufacturing, such as fourth-generation vector systems. These advanced systems are engineered to enhance payload capacity, potency, and safety, while also streamlining the development of complex gene therapies. Fourth-generation vector systems are designed with improved safety profiles, optimized gene packaging capabilities, and modular components that enable scalable, plug-and-play manufacturing for cell and gene therapies. For instance, in May 2023, Oxford Biomedica plc, a UK-based viral vector contract development and manufacturing organization (CDMO), launched the TetraVecta system. This system improves vector quality, potency, and packaging efficiency, while also incorporating advanced safety features. It facilitates the creation of high-titer, stable producer cell lines, supporting scalable in vivo gene therapy development. TetraVecta helps streamline the manufacturing process, reducing production timelines and improving overall efficiency for gene therapy programs.
In October 2025, Oxford Biomedica plc acquired RTP Operating LLC for $4.5 million (£3.4 million) to expand its viral vector manufacturing capabilities in the United States. This acquisition allows Oxford Biomedica (OXB) to enhance its commercial-scale viral vector manufacturing capacity, boosting its end-to-end contract development and manufacturing organization (CDMO) services. It also increases its good manufacturing practice (GMP) capacity, supporting both clinical and commercial gene therapy programs for existing and new clients. RTP Operating LLC, a U.S.-based biopharmaceutical company, provides a commercial-scale viral vector manufacturing facility.
Major companies operating in the viral vector service market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, FUJIFILM Diosynth Biotechnologies, Danaher Corporation, Sartorius AG, CJ CheilJedang Corp., Charles River Laboratories Inc., Takara Bio Inc., Oxford Biomedica plc, ProBioGen AG, NorthX Biologics Ltd., PackGene Biotech Ltd., Ascend Advanced Therapies Ltd., VectorBuilder Inc., ViroCell Biologics Ltd., Genezen Ltd., Scorpius BioManufacturing Ltd., VGXI Inc., Creative Biogene Ltd., ReiThera Ltd., Tailored Genes Ltd., CoJourney Ltd., InnovaVector Ltd., 3PBIOVIAN Ltd.
North America was the largest region in the viral vector service market in 2024. The regions covered in viral vector service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the viral vector service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viral vector service market includes revenues earned by entities through vector design, process development, analytical testing, scale-up production, quality control, regulatory support, purification, and fill and finish. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Vector Service Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on viral vector service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for viral vector service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector service market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Service Type: Process Development; Manufacturing; Quality Control; Other Service Types
2) By Vector Type: Adenoviral Vectors; Lentiviral Vectors; Adeno-Associated Viral Vectors; Retroviral Vectors; Other Vector Types
3) By Application: Gene Therapy; Vaccinology; Oncology; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Research Institutes; Other End-Users
Subsegments:
1) By Process Development: Vector Design; Assay Development; Cell Line Development; Process Optimization
2) By Manufacturing: Upstream Production; Downstream Purification; Formulation Development; Scale-Up Production
3. Viral Vector Service Market Trends And Strategies
4. Viral Vector Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Viral Vector Service Growth Analysis And Strategic Analysis Framework
5.1. Global Viral Vector Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Viral Vector Service Market Growth Rate Analysis
5.4. Global Viral Vector Service Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Viral Vector Service Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Viral Vector Service Total Addressable Market (TAM)
6. Viral Vector Service Market Segmentation
6.1. Global Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Process Development
Manufacturing
Quality Control
Other Service Types
6.2. Global Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adenoviral Vectors
Lentiviral Vectors
Adeno-Associated Viral Vectors
Retroviral Vectors
Other Vector Types
6.3. Global Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Therapy
Vaccinology
Oncology
Other Applications
6.4. Global Viral Vector Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Research Institutes
Other End-Users
6.5. Global Viral Vector Service Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vector Design
Assay Development
Cell Line Development
Process Optimization
6.6. Global Viral Vector Service Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Upstream Production
Downstream Purification
Formulation Development
Scale-Up Production
6.7. Global Viral Vector Service Market, Sub-Segmentation Of Quality Control, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Analytical Testing
Safety Testing
Potency Testing
Stability Testing
7. Viral Vector Service Market Regional And Country Analysis
7.1. Global Viral Vector Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Viral Vector Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Viral Vector Service Market
8.1. Asia-Pacific Viral Vector Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Viral Vector Service Market
9.1. China Viral Vector Service Market Overview
9.2. China Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Viral Vector Service Market
10.1. India Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Viral Vector Service Market
11.1. Japan Viral Vector Service Market Overview
11.2. Japan Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Viral Vector Service Market
12.1. Australia Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Viral Vector Service Market
13.1. Indonesia Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Viral Vector Service Market
14.1. South Korea Viral Vector Service Market Overview
14.2. South Korea Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Viral Vector Service Market
15.1. Western Europe Viral Vector Service Market Overview
15.2. Western Europe Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Viral Vector Service Market
16.1. UK Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Viral Vector Service Market
17.1. Germany Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Viral Vector Service Market
18.1. France Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Viral Vector Service Market
19.1. Italy Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Viral Vector Service Market
20.1. Spain Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Viral Vector Service Market
21.1. Eastern Europe Viral Vector Service Market Overview
21.2. Eastern Europe Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Viral Vector Service Market
22.1. Russia Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Viral Vector Service Market
23.1. North America Viral Vector Service Market Overview
23.2. North America Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Viral Vector Service Market
24.1. USA Viral Vector Service Market Overview
24.2. USA Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Viral Vector Service Market
25.1. Canada Viral Vector Service Market Overview
25.2. Canada Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Viral Vector Service Market
26.1. South America Viral Vector Service Market Overview
26.2. South America Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Viral Vector Service Market
27.1. Brazil Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Viral Vector Service Market
28.1. Middle East Viral Vector Service Market Overview
28.2. Middle East Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Viral Vector Service Market
29.1. Africa Viral Vector Service Market Overview
29.2. Africa Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Viral Vector Service Market Competitive Landscape And Company Profiles
30.1. Viral Vector Service Market Competitive Landscape
30.2. Viral Vector Service Market Company Profiles
30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. FUJIFILM Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Viral Vector Service Market Other Major And Innovative Companies
31.1. Sartorius AG
31.2. CJ CheilJedang Corp.
31.3. Charles River Laboratories Inc.
31.4. Takara Bio Inc.
31.5. Oxford Biomedica plc
31.6. ProBioGen AG
31.7. NorthX Biologics Ltd.
31.8. PackGene Biotech Ltd.
31.9. Ascend Advanced Therapies Ltd.
31.10. VectorBuilder Inc.
31.11. ViroCell Biologics Ltd.
31.12. Genezen Ltd.
31.13. Scorpius BioManufacturing Ltd.
31.14. VGXI Inc.
31.15. Creative Biogene Ltd.
32. Global Viral Vector Service Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Viral Vector Service Market
34. Recent Developments In The Viral Vector Service Market
35. Viral Vector Service Market High Potential Countries, Segments and Strategies
35.1 Viral Vector Service Market In 2029 - Countries Offering Most New Opportunities
35.2 Viral Vector Service Market In 2029 - Segments Offering Most New Opportunities
35.3 Viral Vector Service Market In 2029 - Growth Strategies
